+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Probiotics Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 181 Pages
  • November 2025
  • Region: Global
  • 360iResearch™
  • ID: 5311181
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The probiotics market is undergoing significant transformation as industry innovation, scientific advancements, and evolving consumer health priorities drive broad adoption and segmentation across multiple verticals.

Market Snapshot: Probiotics Market


The probiotics market grew from USD 70.34 billion in 2024 to USD 77.20 billion in 2025. It is projected to continue at a robust CAGR of 10.30%, reaching USD 154.17 billion by 2032. Widespread awareness of the connection between gut microbiota and personal wellness, combined with product innovation, is fueling sector resilience and long-term expansion. Key drivers include rising demand for tailored health solutions, intensive research unlocking novel strain-specific benefits, and diversification into new delivery formats across multiple industries.

Scope & Segmentation

  • Product Types: Dietary supplements (capsules, powders, tablets), feed, food and beverage (dairy, non-dairy), personal care products (haircare, skincare).
  • Sources: Bacteria-based probiotics and yeast-derived strains offering stability and distinctive health properties.
  • Applications: Digestive health, immune health, oral health, urogenital health solutions for human and animal end-users.
  • Distribution Channels: Offline outlets (pharmacies, specialty stores) and online channels, including subscription models and direct-to-consumer strategies.
  • Key Regions: Americas (North America, Latin America), Europe Middle East & Africa (United Kingdom, Germany, France, Middle East, Africa), Asia-Pacific (China, India, Japan, Australia, and more).
  • Leading Technologies: Microencapsulation, next-generation sequencing, and digital health platforms used to enhance probiotic development, stability, and personalization.
  • Featured Companies: Alltech, Inc., Archer Daniels Midland Company, Arla Foods, Asahi Group Holdings, BioGaia AB, Chr. Hansen Holding, DuPont de Nemours, Evonik Industries, Kerry Group, Lallemand, and others.

Key Takeaways for Decision-Makers

  • Scientific research and regulatory accountability are enabling precise, evidence-backed claims for probiotic efficacy, boosting consumer trust and market transparency.
  • Delivery innovation is expanding the spectrum of product formats, supporting both conventional supplements and new opportunities in functional foods, beverages, and personal care.
  • Collaborative R&D and strategic partnerships accelerate market entry while enabling compliance with diverse regional regulations.
  • Sustainability initiatives in production and raw material sourcing enhance supply chain resilience and support environmental stewardship across the industry.
  • The shift toward digital engagement and subscription-based models supports higher customer retention and offers accessible, tailored probiotic regimens to new demographics.
  • Personalized formulations for both human and animal health drive engagement and strengthen customer loyalty, expanding the value proposition for multiple application areas.

Tariff Impact: Navigating U.S. Policy Changes

The 2025 introduction of enhanced U.S. tariffs has prompted probiotics stakeholders to reconfigure global supply chains, stimulate regional production hubs, and diversify sourcing. These shifts are driving cost management initiatives and reinforcing supply network agility, ultimately leading to a broader, more resilient market ecosystem prepared for potential future policy shifts.

Methodology & Data Sources

This analysis utilizes a mixed-method research approach that incorporates direct interviews with senior industry executives, scientists, supply chain experts, and commercialization strategists. These insights are cross-referenced with secondary intelligence from regulatory filings, peer-reviewed journals, and proprietary databases. Data triangulation and cross-regional mapping techniques have been employed to ensure balanced and actionable findings.

Why This Report Matters

  • Provides actionable insights for strategic planning, including technology priorities, supply chain optimization, and market expansion pathways tailored to senior leadership needs.
  • Enables competitive benchmarking of key players and identifies opportunities for differentiation through innovation, sustainability, and digital engagement.
  • Offers a detailed framework for assessing regional trends and understanding shifting policy and regulatory impacts on business operations.

Conclusion

With evolving health priorities, scientific rigor, and regulatory frameworks shaping the probiotics landscape, stakeholders poised to act on these insights will be well equipped to sustain growth, innovation, and resilience within this expanding ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Expansion of precision probiotics targeting individualized microbiome profiles in human health management
5.2. Rising adoption of synbiotic formulations combining prebiotic fibers with live probiotic strains for gut health improvement
5.3. Growth in postbiotic applications leveraging non-viable microbial metabolites for improved safety and stability
5.4. Increased investment in R&D for next-generation psychobiotics addressing mental health through gut-brain axis modulation
5.5. Surge in shelf-stable probiotic supplement formats optimized for ambient storage without refrigeration
5.6. Consumer demand driving development of plant-based dairy-free probiotic alternatives using oat and almond matrices
5.7. Integration of probiotics into everyday consumer products such as snacks, beverages and personal care for holistic microbiome support
5.8. Regulatory shifts enabling qualified health claims for probiotic products based on strain-specific clinical evidence
5.9. Strategic partnerships between probiotics manufacturers and e-commerce platforms to enhance direct-to-consumer sales channels
5.10. Advancements in microencapsulation technologies enhancing probiotic survival through gastric transit to the colon
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Probiotics Market, by Product Type
8.1. Dietary Supplements
8.1.1. Capsules
8.1.2. Powders
8.1.3. Tablets
8.2. Feed
8.3. Food & Beverage
8.3.1. Dairy
8.3.2. Non-Dairy
8.4. Personal Care Products
8.4.1. Haircare
8.4.2. Skincare
9. Probiotics Market, by Source
9.1. Bacteria
9.2. Yeast
10. Probiotics Market, by Application
10.1. Digestive Health
10.2. Immune Health
10.3. Oral Health
10.4. Urogenital Health
11. Probiotics Market, by End-User
11.1. Animal
11.2. Human
12. Probiotics Market, by Distribution Channel
12.1. Offline
12.2. Online
13. Probiotics Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Probiotics Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Probiotics Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Alltech, Inc.
16.3.2. Archer Daniels Midland Company
16.3.3. Arla Foods, Inc.
16.3.4. Asahi Group Holdings, Ltd.
16.3.5. Bio Armor Developpement S.A.R.L. by The Kersia Group
16.3.6. BioCC LLC
16.3.7. BioGaia AB
16.3.8. Chr. Hansen Holding A/S
16.3.9. DuPont de Nemours, Inc.
16.3.10. Evonik Industries AG
16.3.11. Greentech
16.3.12. Kerry Group PLC
16.3.13. Lallemand Inc.
16.3.14. Land O'lakes, Inc.
16.3.15. Lesaffre & CIE
16.3.16. Lifeway Foods, Inc.
16.3.17. MITUSHI BIOPHARMA
16.3.18. Morinaga Milk Industry Co., Ltd.
16.3.19. Mother Dairy Fruit & Vegetable Pvt. Ltd.
16.3.20. Nestlé S.A.
16.3.21. Novozymes A/S
16.3.22. Probi AB
16.3.23. Probiotical SpA
16.3.24. Provita Eurotech Limited
16.3.25. Reckitt Benckiser Group plc
16.3.26. Roelmi HPC
16.3.27. Royal DSM N.V.
16.3.28. Sabinsa Corporation
16.3.29. Schouw & Co.
16.3.30. Synbio Tech Inc.
16.3.31. Yakult Honsha Co., Ltd.

Companies Mentioned

The companies profiled in this Probiotics market report include:
  • Alltech, Inc.
  • Archer Daniels Midland Company
  • Arla Foods, Inc.
  • Asahi Group Holdings, Ltd.
  • Bio Armor Developpement S.A.R.L. by The Kersia Group
  • BioCC LLC
  • BioGaia AB
  • Chr. Hansen Holding A/S
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • Greentech
  • Kerry Group PLC
  • Lallemand Inc.
  • Land O'lakes, Inc.
  • Lesaffre & CIE
  • Lifeway Foods, Inc.
  • MITUSHI BIOPHARMA
  • Morinaga Milk Industry Co., Ltd.
  • Mother Dairy Fruit & Vegetable Pvt. Ltd.
  • Nestlé S.A.
  • Novozymes A/S
  • Probi AB
  • Probiotical SpA
  • Provita Eurotech Limited
  • Reckitt Benckiser Group plc
  • Roelmi HPC
  • Royal DSM N.V.
  • Sabinsa Corporation
  • Schouw & Co.
  • Synbio Tech Inc.
  • Yakult Honsha Co., Ltd.

Table Information